5 studies found for: (lymphoma [CONDITION] OR CLL [CONDITION]) AND Zanolimumab [TREATMENT]
HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.
Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.
CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
† Study has passed its completion date and status has not been verified in more than two years.